Bringing safe, effective therapies to market requires consistent analytical rigor across discovery, development, clinical trials and commercial release. As programs progress, the demand for reliable, regulatory-ready data continues to rise across an increasingly broad range of therapeutic modalities, from small molecules and biologics to advanced therapies such as cell and gene therapy, mRNA and CAR-T.
We deliver a full range of bioanalytical services to support drug development across the life cycle. Our globally compliant laboratories combine advanced analytical platforms with in-depth scientific expertise, helping pharma and biotech developers maintain quality, compliance and data integrity from early research to commercialization.
Looking for something specific?
Search within Bioanalysis